Treatment of circadian rhythm disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE46604
SERIAL NO

15051978

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VANDA PHARMACEUTICALS INC2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dressman, Marlene Michelle Germantown, US 44 217
Feeney, John Joseph Olney, US 23 135
Licamele, Louis William Potomac, US 46 163
Polymeropoulos, Mihael H Potomac, US 136 427

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 14, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 14, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00